- Report
- August 2023
- 1500 Pages
Global
From €8307EUR$8,750USD£7,007GBP
- Report
- January 2023
- 195 Pages
Latin America
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2022
- 348 Pages
Singapore, Malaysia, Indonesia Singapore, Malaysia, Indonesia
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2022
- 220 Pages
United States
From €4747EUR$5,000USD£4,004GBP
- Report
- June 2022
- 55 Pages
India
From €4747EUR$5,000USD£4,004GBP
- Report
- June 2021
- 197 Pages
Latin America
From €3797EUR$4,000USD£3,203GBP
- Report
- February 2024
- 72 Pages
South Korea
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2022
- 312 Pages
Global
From €6645EUR$7,000USD£5,605GBP
- Report
- September 2021
- 144 Pages
China
From €3797EUR$4,000USD£3,203GBP
- Report
- February 2024
- 218 Pages
Japan
From €1346EUR$1,418USD£1,135GBP
€1794EUR$1,890USD£1,513GBP
- Report
- February 2024
- 209 Pages
Europe
From €3940EUR$4,150USD£3,323GBP
- Report
- September 2023
- 141 Pages
Global
From €2136EUR$2,250USD£1,802GBP
- Report
- January 2024
- 120 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- November 2022
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- January 2025
- 84 Pages
Vietnam
From €3323EUR$3,500USD£2,803GBP
- Report
- July 2024
- 88 Pages
India
From €3323EUR$3,500USD£2,803GBP
- Report
- March 2024
- 200 Pages
Global
From €3940EUR$4,150USD£3,323GBP
- Report
- January 2025
Australia
From €902EUR$950USD£761GBP
- Report
- May 2024
South Korea
From €1756EUR$1,850USD£1,481GBP
From €1756EUR$1,850USD£1,481GBP

The Tumor Marker market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect the presence of cancer in a patient. These products are typically used to diagnose, monitor, and assess the effectiveness of cancer treatments. Tumor markers are typically proteins, hormones, or other substances that are produced by cancer cells or by the body in response to cancer. They can be detected in the blood, urine, or other body fluids.
The Tumor Marker market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cancer and the need for early diagnosis and effective treatment. The market is expected to continue to grow in the coming years, driven by technological advancements and the development of new products.
Some of the major companies in the Tumor Marker market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more